Recent studies have revealed that cDCs contribute to LN by presenting autoantigens in the kidney: single‐cell profiling has identified CD163+ cDCs in patients with LN, emphasizing their role in renal inflammation [102]. Here, CD163 is linked to lobular neoplasia.